(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

NCT04996875 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Systemic Mastocytosis (AdvSM)
SM With an Associated Hematologic Neoplasm (SM-AHN)
Mast Cell Leukemia (MCL)
Aggressive Systemic Mastocytosis (ASM)

Interventions

DRUG: bezuclastinib

Sponsor

Cogent Biosciences, Inc.